Skip to Content, Navigation, or Footer.
The Tufts Daily
Where you read it first | Sunday, June 16, 2024

Meg Radke

13587648-c25b-4f4e-bbcc-1e4de7320c58 (1).jpg

Meet Professor Shelly Peyton, incoming biomedical engineering chair

Professor Shelly Peyton will be joining the Tufts Department of Biomedical Engineering in July. The department was founded in 2002 and chaired by Professor David Kaplan. Kaplan stepped down in 2022, and Professor Sergio Fantini has served as the interim chair over the past two years until Peyton takes over. Last week, I was able to sit down and interview her about her background and her plans as the new chair.


Phenylephrine: The decongestant that leaves you stuffy

Going into winter, your cold medicines could end up looking a little different based on a forthcoming decision from the FDA. Phenylephrine is an over-the-counter decongestant in many different medicines, including Dayquil Cold and Flu Relief, Sudafed PE and Benadryl Allergy Plus Congestion. But an FDA advisory board recently concluded that at current dosages, oral phenylephrine is not effective. The independent advisory committee, assembled by the FDA, will now review the findings and determine whether phenylephrine is effective. If they come to the same conclusion that the committee did — which they often do — there would be a process to remove medications with phenylephrine from the shelves, and medications containing phenylephrine, especially those containing multiple active ingredients, such as Dayquil, would need to be reformulated. CVS has already announced that it will stop selling products containing oral phenylephrine.

More articles »